Profile
1955 Capital is a venture capital firm based in Los Altos, California, founded in 2016 by Andrew Chung, a former General Partner at Khosla Ventures. The firm focuses on bridging the translational gap in science, investing in early-stage companies that leverage advances in biology, materials, and computation. With a team of 5 professionals, 1955 Capital is known for its thesis-driven, operator-led approach, working closely with founders to accelerate the path from lab to scale.
The firm invests in sectors such as energy, infrastructure, biology, health, food, and computation, with a particular focus on technologies that can be applied to real-world systems. 1955 Capital typically invests in Series A and Series B rounds, with an average check size of $5-10 million. The firm primarily targets companies in the United States and Europe, aiming to solve pressing problems in developing countries and then bring those solutions back to developed markets.
Notable investments by 1955 Capital include AcuamarkDx - diagnostic equipment, Craif - biotechnology, Vital Bio - laboratory services, Noah Medical - diagnostic equipment, and Gridtential Energy - energy storage. These investments reflect the firm's commitment to advancing foundational technologies across various industries.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.